Your Health, We Care
The recommended starting dose of lemborexant is 5 mg.
The dose may be increased to a maximum recommended dose of 10 mg based on clinical response and tolerability.
No dose adjustment is required based on age, gender, body mass index (BMI), or renal impairment.
Caution should be exercised when using the 10 mg dose in patients aged ≥65 years.
Patients with severe renal impairment may be at an increased risk of somnolence.
The maximum recommended dose for patients with moderate hepatic impairment is 5 mg nightly. The use of lemborexant is not recommended in patients with severe hepatic impairment.
Patients with mild hepatic impairment may be at an increased risk of somnolence.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
